Related Experiment Video
Updated: May 18, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
CHOP and caspase 3 induction underlie glioblastoma cell death in response to endoplasmic reticulum stress
Quincy A Quick1, Milton O Faison
1Department of Biology, Southern University at New Orleans, New Orleans, LA 70126;
Abstract:
The unfolded protein endoplasmic reticulum stress response has emerged as a cellular physiological target to invoke tumor cell killing due to its homeostatic and cytoprotective functions. In this study, thapsigargin and tunicamycin, two endoplasmic reticulum stress inducers, were investigated for their efficacy on glioblastomas. We demonstrate that clinically relevant concentrations of thapsigargin and tunicamycin eliminate the glioblastoma cell reproductive capacity as a consequence of cell death. The mode of glioblastoma-induced cell death was determined to be via apoptosis as supported by increased C/EBP homologous protein (CHOP) levels and caspase 3 activity, two proteins with established roles in endoplasmic reticulum stress-induced cell death. In conclusion, this study provides evidence that glioblastomas are responsive to endoplasmic reticulum stress induction as a cellular program to eradicate this tumor via programmed cell death.
Insights
Endoplasmic reticulum stress inducers thapsigargin and tunicamycin effectively kill glioblastoma cells. This programmed cell death, triggered by endoplasmic reticulum stress, halts tumor cell reproduction.
Area of Science:
- Oncology
- Cellular Biology
- Molecular Biology
Background:
- The unfolded protein response (UPR) in the endoplasmic reticulum (ER) plays a crucial role in cellular homeostasis and protection.
- Targeting ER stress pathways offers a potential strategy for cancer therapy due to their involvement in tumor cell survival.
- Glioblastomas are aggressive brain tumors with limited treatment options, necessitating novel therapeutic approaches.
Purpose of the Study:
- To investigate the efficacy of ER stress inducers, thapsigargin and tunicamycin, in eliminating glioblastoma cells.
- To determine the mechanism of glioblastoma cell death induced by ER stress.
- To establish ER stress induction as a potential therapeutic strategy against glioblastomas.
Main Methods:
- Treatment of glioblastoma cells with clinically relevant concentrations of thapsigargin and tunicamycin.
- Assessment of glioblastoma cell reproductive capacity and cell death.
- Measurement of C/EBP homologous protein (CHOP) levels and caspase 3 activity as indicators of apoptosis.
Main Results:
- Thapsigargin and tunicamycin at clinically relevant concentrations significantly reduced glioblastoma cell reproductive capacity.
- Induction of ER stress led to glioblastoma cell death.
- Elevated levels of CHOP and caspase 3 activity confirmed apoptosis as the mode of cell death.
Conclusions:
- Glioblastomas are susceptible to cell death induction via ER stress.
- ER stress inducers demonstrate potential as a therapeutic strategy for glioblastoma eradication.
- Targeting the ER stress pathway represents a promising avenue for glioblastoma treatment.
More Related Videos
08:41Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Published on: January 13, 2012
Related Concept Videos
Caspases
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway
The Unfolded Protein Response
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Export of Misfolded Proteins out of the ER